Search

Your search keyword '"Castro de la Nuez, Pablo"' showing total 122 results
Start Over Author "Castro de la Nuez, Pablo"
122 results on '"Castro de la Nuez, Pablo"'

2. Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in Europe

Author

Stel, Vianda S., de Jong, Rianne W., Kramer, Anneke, Andrusev, Anton M., Baltar, José M., Barbullushi, Myftar, Bell, Samira, Castro de la Nuez, Pablo, Cernevskis, Harijs, Couchoud, Cécile, De Meester, Johan, Eriksen, Bjørn O., Gârneaţă, Liliana, Golan, Eliezer, Helve, Jaakko, Hemmelder, Marc H., Hommel, Kristine, Ioannou, Kyriakos, Jarraya, Faiçal, Kantaria, Nino, Kerschbaum, Julia, Komissarov, Kirill S., Magaz, Ángela, Mercadal, Lucile, Ots-Rosenberg, Mai, Pálsson, Runólfur, Rahmel, Axel, Rydell, Helena, Savino, Manuela, Seyahi, Nurhan, Slon Roblero, Maria F., Stojceva-Taneva, Olivera, van der Tol, Arjan, Vazelov, Evgueniy S., Ziginskiene, Edita, Zurriaga, Óscar, Vanholder, Raymond C., Massy, Ziad A., and Jager, Kitty J.

Published
2021
Full Text
View/download PDF

3. Predicting Kidney Transplantation Outcomes from Donor and Recipient Characteristics at Time Zero: Development of a Mobile Application for Nephrologists.

Author

Pérez Valdivia, Miguel Ángel, Calvillo Arbizu, Jorge, Portero Barreña, Daniel, Castro de la Nuez, Pablo, López Jiménez, Verónica, Rodríguez Benot, Alberto, Mazuecos Blanca, Auxiliadora, de Gracia Guindo, Mª Carmen, Bernal Blanco, Gabriel, Gentil Govantes, Miguel Ángel, Bedoya Pérez, Rafael, and Rocha Castilla, José Luis

Subjects
KIDNEY transplantation, TREATMENT effectiveness, MOBILE apps, NEPHROLOGISTS, OVERALL survival
Abstract

(1) Background: We report on the development of a predictive tool that can estimate kidney transplant survival at time zero. (2) Methods: This was an observational, retrospective study including 5078 transplants. Death-censored graft and patient survivals were calculated. (3) Results: Graft loss was associated with donor age (hazard ratio [HR], 1.021, 95% confidence interval [CI] 1.018–1.024, p < 0.001), uncontrolled donation after circulatory death (DCD) (HR 1.576, 95% CI 1.241–2.047, p < 0.001) and controlled DCD (HR 1.567, 95% CI 1.372–1.812, p < 0.001), panel reactive antibody percentage (HR 1.009, 95% CI 1.007–1.011, p < 0.001), and previous transplants (HR 1.494, 95% CI 1.367–1.634, p < 0.001). Patient survival was associated with recipient age (> 60 years, HR 5.507, 95% CI 4.524–6.704, p < 0.001 vs. < 40 years), donor age (HR 1.019, 95% CI 1.016–1.023, p < 0.001), dialysis vintage (HR 1.0000263, 95% CI 1.000225–1.000301, p < 0.01), and male sex (HR 1.229, 95% CI 1.135–1.332, p < 0.001). The C-statistics for graft and patient survival were 0.666 (95% CI: 0.646, 0.686) and 0.726 (95% CI: 0.710–0.742), respectively. (4) Conclusions: We developed a mobile app to estimate survival at time zero, which can guide decisions for organ allocation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. The ERA Registry Annual Report 2021: a summary

Author

Boerstra, Brittany A, primary, Boenink, Rianne, additional, Astley, Megan E, additional, Bonthuis, Marjolein, additional, Abd ElHafeez, Samar, additional, Arribas Monzón, Federico, additional, Åsberg, Anders, additional, Beckerman, Pazit, additional, Bell, Samira, additional, Cases Amenós, Aleix, additional, Castro de la Nuez, Pablo, additional, ten Dam, Marc A G J, additional, Debska-Slizien, Alicja, additional, Gjorgjievski, Nikola, additional, Giudotti, Rebecca, additional, Helve, Jaakko, additional, Hommel, Kristine, additional, Idrizi, Alma, additional, Indriðason, Ólafur S, additional, Jarraya, Faiçal, additional, Kerschbaum, Julia, additional, Komissarov, Kirill S, additional, Kozliuk, Nadiia, additional, Kravljaca, Milica, additional, Lassalle, Mathilde, additional, De Meester, Johan M, additional, Ots-Rosenberg, Mai, additional, Plummer, Zoe, additional, Radunovic, Danilo, additional, Razvazhaieva, Olena, additional, Resic, Halima, additional, Rodríguez Arévalo, Olga Lucía, additional, Santiuste de Pablos, Carmen, additional, Seyahi, Nurhan, additional, Slon-Roblero, María Fernanda, additional, Stendahl, Maria, additional, Tolaj-Avdiu, Miloreta, additional, Trujillo-Alemán, Sara, additional, Ziedina, Ieva, additional, Ziginskiene, Edita, additional, Ortiz, Alberto, additional, Jager, Kitty J, additional, Stel, Vianda S, additional, and Kramer, Anneke, additional

Published
2023
Full Text
View/download PDF

6. ¿Predice el Kidney Donor Profile Index (KDPI) la supervivencia del injerto y del paciente en una población española?

Author

Calvillo-Arbizu, Jorge, Pérez-Valdivia, Miguel A., Gentil-Govantes, Miguel A., Castro-de-la-Nuez, Pablo, Mazuecos-Blanca, Auxiliadora, Rodríguez-Benot, Alberto, Gracia-Guindo, María C., Borrego-Utiel, Francisco, Cabello-Díaz, Mercedes, Bedoya-Pérez, Rafael, Alonso-Gil, Manuel, Salgueira-Lazo, Mercedes, and Roa-Romero, Laura M.

Published
2018
Full Text
View/download PDF

7. The ERA Registry Annual Report 2020: a summary

Author

Astley, Megan E, primary, Boenink, Rianne, additional, ElHafeez, Samar Abd, additional, Trujillo-Alemán, Sara, additional, Arribas, F, additional, Åsberg, Anders, additional, Beckerman, Pazit, additional, Bell, Samira, additional, Bouzas-Caamaño, María Encarnación, additional, Farnés, Jordi Comas, additional, Galvão, Ana Amélia, additional, Gjorgjievski, Nikola, additional, Kelmendi, Vjollca Godanci, additional, Guidotti, Rebecca, additional, Helve, Jaakko, additional, Idrizi, Alma, additional, Indriðason, Ólafur S, additional, Ioannou, Kyriakos, additional, Kerschbaum, Julia, additional, Komissarov, Kirill, additional, Castro de la Nuez, Pablo, additional, Lassalle, Mathilde, additional, Nordio, Maurizio, additional, Arévalo, Olga Lucía Rodríguez, additional, Santiuste, Carmen, additional, Seyahi, Nurhan, additional, Roblero, María Fernanda Slon, additional, Steenkamp, Retha, additional, ten Dam, Marc A G J, additional, Zakharova, Elena V, additional, Ziginskiene, Edita, additional, Bonthuis, Marjolein, additional, Stel, Vianda S, additional, Ortiz, Alberto, additional, Jager, Kitty J, additional, and Kramer, Anneke, additional

Published
2023
Full Text
View/download PDF

9. Prognosis factors of patients undergoing renal replacement therapy

Author

Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Medicina Preventiva y Salud Pública, Muñoz Terol, José Manuel, Rocha Castilla, José Luis, Castro de la Nuez, Pablo, Egea Guerrero, Juan José, Gil Sacaluga, Luis, García Cabrera, Emilio, Vilches Arenas, Ángel, Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Medicina Preventiva y Salud Pública, Muñoz Terol, José Manuel, Rocha Castilla, José Luis, Castro de la Nuez, Pablo, Egea Guerrero, Juan José, Gil Sacaluga, Luis, García Cabrera, Emilio, and Vilches Arenas, Ángel

Abstract

Background: Survival in patients with end-stage kidney disease (ESKD) on renal replacement therapy (RRT) is less than that of the general population of the same age, and depends on patient factors, the medical care received, and the type of RRT used. The objective of this study is to analyze the factors associated with survival in patients undergoing RRT. Methods: We conducted a retrospective observational study of adult patients with an incident of ESKD on RRT in Andalusia from 1 January 2008 to 31 December 2018. Patient characteristics, nephrological care received, and survival from the beginning of RRT were evaluated. A survival model for the patient was developed according to the variables studied. Results: A total of 11,551 patients were included. Median survival was 6.8 years (95% CI (6.6; 7.0)). After starting RRT, survival at one year and five years was 88.7% (95% CI (88.1; 89.3)) and 59.4% (95% CI (58.4; 60.4)), respectively. Age, initial comorbidity, diabetic nephropathy, and a venous catheter were independent risk factors. However, non-urgent initiation of RRT and follow-up in consultations for more than six months had a protective effect. It was identified that renal transplantation (RT) was the most influential independent factor in patient survival, with a risk ratio of 0.13 (95% CI (0.11; 0.14)). Conclusions: The receiving of a kidney transplant was the most beneficial modifiable factor in the survival of incident patients on RRT. We consider that the mortality of the renal replacement treatment should be adjusted, taking into account both modifiable and nonmodifiable factors to achieve a more precise and comparable interpretation.

Published
2023

10. Years of potential life lost on renal replacement therapy: retrospective study cohort

Author

Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Medicina Preventiva y Salud Pública, Muñoz Terol, José Manuel, Rocha Castilla, José Luis, Castro-de la Nuez, Pablo, García Cabrera, Emilio, Vilches Arenas, Ángel, Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Medicina Preventiva y Salud Pública, Muñoz Terol, José Manuel, Rocha Castilla, José Luis, Castro-de la Nuez, Pablo, García Cabrera, Emilio, and Vilches Arenas, Ángel

Abstract

Chronic kidney disease is the non-communicable disease with the highest growth in morbidity and mortality. Renal transplantation (RT) is the first option of renal replacement in end-stage kidney disease (ESKD) and dialysis is an alternative. However, there is no objective quantification of the impact of both options on a patient’s overall survival. The purpose of our study is to assess the potential years of life lost by patients on renal replacement therapy. Methods: Retrospective study cohort conducted from 2008 to 2018 based on autonomic data registry. Results: 11,551 patients included who received renal replacement therapy (RRT) in a range of age from 15 to 94 years. The mean age at the time of onset was 62.7 years, 95% confidence interval (95% CI) (62.4; 63.0). The mortality rate of RRT patients was 42.2%, 95% CI (41.5; 43.3) and the mean age at death was 72.7 years, 95% CI (72.4; 73.1). The number of patients with ESKD treated with RT was 3776, 32.7% of the total, 95% CI (31.8; 33.5). The total amount of years of potential life lost (YPLL) in the entire cohort was 77,831.3 years, 48,010.1 years in men, and 29,821.2 years in women. The mean number of YPLL per patient with RRT was 6.74 years in both sexes, 6.95 years in women, and 6.61 years in men. The mean number of potential years of life lost in dialysis patients was 9.0 years in both sexes, 8.8 years in men, and 9.2 years in women, while among kidney transplant recipients this figure decreased to 2.2 years in both men and women. Conclusions: End-stage chronic kidney disease in renal replacement therapy by dialysis causes an average of 9.0 years of life potentially lost for each patient on dialysis treatment, while having received a kidney transplant reduces this figure by 75.6%.

Published
2023

11. Comparative Study of the Impact of Human Leukocyte Antigens on Renal Transplant Survival in Andalusia and the United States

Author

Universidad de Sevilla. Departamento de Teoría de la Señal y la Comunicación, Universidad de Sevilla. Departamento de Ingeniería Telemática, Universidad de Sevilla. TIC203: Ingeniería Biomédica, Fundación Mutua Madrileña, Proyecto VÍA-RENAL, Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidad, Talaminos Barroso, Alejandro, Reina Tosina, Luis Javier, Roa Romero, Laura Maria, Calvillo Arbizu, Jorge, Pérez Valdivia, Miguel Angel, Medina, Rafael, Rocha Castilla, José Luis, Castro de la Nuez, Pablo, Universidad de Sevilla. Departamento de Teoría de la Señal y la Comunicación, Universidad de Sevilla. Departamento de Ingeniería Telemática, Universidad de Sevilla. TIC203: Ingeniería Biomédica, Fundación Mutua Madrileña, Proyecto VÍA-RENAL, Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidad, Talaminos Barroso, Alejandro, Reina Tosina, Luis Javier, Roa Romero, Laura Maria, Calvillo Arbizu, Jorge, Pérez Valdivia, Miguel Angel, Medina, Rafael, Rocha Castilla, José Luis, and Castro de la Nuez, Pablo

Abstract

Renal transplantation is the treatment of choice for patients suffering from chronic renal disease, one of the leading causes of death worldwide. Among the biological barriers that may increase the risk of acute renal graft rejection is the presence of human leukocyte antigen (HLA) incompatibilities between donor and recipient. This work presents a comparative study of the influence of HLA incompatibilities on renal transplantation survival in the Andalusian (South of Spain) and United States (US) population. The main objective is to analyse the extent to which results about the influence of different factors on renal graft survival can be generalised to different populations. The Kaplan–Meier estimator and the Cox model have been used to identify and quantify the impact on the survival probability of HLA incompatibilities, both in isolation and in conjunction with other factors associated with the donor and recipient. According to the results obtained, HLA incompatibilities considered in isolation have negligible impact on renal survival in the Andalusian population and a moderate impact in the US population. Grouping by HLA score presents some similarities for both populations, while the sum of all HLA scores (aHLA) only has an impact on the US population. Finally, the graft survival probability of the two populations differs when aHLA is considered in conjunction with blood type. The results suggest that the disparities in the renal graft survival probability between the two populations under study are due not only to biological and transplantation-associated factors, but also to social–health factors and ethnic heterogeneity between populations.

Published
2023

12. Prognosis Factors of Patients Undergoing Renal Replacement Therapy

Author

Muñoz-Terol, José Manuel, Rocha, José L., Castro-de la Nuez, Pablo, Egea-Guerrero, Juan José, Gil-Sacaluga, Luis, García-Cabrera, Emilio, Vilches-Arenas, A., Muñoz-Terol, José Manuel, Rocha, José L., Castro-de la Nuez, Pablo, Egea-Guerrero, Juan José, Gil-Sacaluga, Luis, García-Cabrera, Emilio, and Vilches-Arenas, A.

Abstract

Background: Survival in patients with end-stage kidney disease (ESKD) on renal replacement therapy (RRT) is less than that of the general population of the same age, and depends on patient factors, the medical care received, and the type of RRT used. The objective of this study is to analyze the factors associated with survival in patients undergoing RRT. Methods: We conducted a retrospective observational study of adult patients with an incident of ESKD on RRT in Andalusia from 1 January 2008 to 31 December 2018. Patient characteristics, nephrological care received, and survival from the beginning of RRT were evaluated. A survival model for the patient was developed according to the variables studied. Results: A total of 11,551 patients were included. Median survival was 6.8 years (95% CI (6.6; 7.0)). After starting RRT, survival at one year and five years was 88.7% (95% CI (88.1; 89.3)) and 59.4% (95% CI (58.4; 60.4)), respectively. Age, initial comorbidity, diabetic nephropathy, and a venous catheter were independent risk factors. However, non-urgent initiation of RRT and follow-up in consultations for more than six months had a protective effect. It was identified that renal transplantation (RT) was the most influential independent factor in patient survival, with a risk ratio of 0.13 (95% CI (0.11; 0.14)). Conclusions: The receiving of a kidney transplant was the most beneficial modifiable factor in the survival of incident patients on RRT. We consider that the mortality of the renal replacement treatment should be adjusted, taking into account both modifiable and nonmodifiable factors to achieve a more precise and comparable interpretation.

Published
2023

14. Clinical evolution of chronic renal patients with HIV infection in replacement therapy

Author

Saracho, Ramón, Martín Escobar, Eduardo, Comas Farnés, Jordi, Arcos, Emma, Mazuecos Blanca, Auxiliadora, Gentil Govantes, Miguel Ángel, Castro de la Nuez, Pablo, Zurriaga, Óscar, Ferrer Alamar, Manuel, Bouzas Caamaño, Encarnación, García Falcón, Teresa, Portolés Pérez, José, Herrero Calvo, José A., Chamorro Jambrina, Carlos, Moina Eguren, Íñigo, Rodrigo de Tomás, María Teresa, Abad Díez, José María, Sánchez Miret, José I., Alvarez Lipe, Rafael, Díaz Tejeiro, Rafael, Moreno Alía, Inmaculada, Torres Guinea, Marta, Huarte Loza, Enma, Artamendi Larrañaga, Marta, Fernández Renedo, Carlos, González Fernández, Raquel, Sánchez Álvarez, Emilio, and Alonso de la Torre, Ramón

Published
2015
Full Text
View/download PDF

15. Evolución clínica de los enfermos renales crónicos en tratamiento sustitutivo con infección por VIH

Author

Saracho, Ramón, Martín Escobar, Eduardo, Comas Farnés, Jordi, Arcos, Emma, Mazuecos Blanca, Auxiliadora, Gentil Govantes, Miguel Ángel, Castro de la Nuez, Pablo, Zurriaga, Óscar, Ferrer Alamar, Manuel, Bouzas Caamaño, Encarnación, García Falcón, Teresa, Portolés Pérez, José, Herrero Calvo, José A., Chamorro Jambrina, Carlos, Moina Eguren, Íñigo, Rodrigo de Tomás, María Teresa, Abad Díez, José María, Sánchez Miret, José I., Alvarez Lipe, Rafael, Díaz Tejeiro, Rafael, Moreno Alía, Inmaculada, Torres Guinea, Marta, Huarte Loza, Enma, Artamendi Larrañaga, Marta, Fernández Renedo, Carlos, González Fernández, Raquel, Sánchez Álvarez, Emilio, and Alonso de la Torre, Ramón

Published
2015
Full Text
View/download PDF

18. The ERA Registry Annual Report 2019:Summary and age comparisons

Author

Boenink, Rianne, Astley, Megan E., Huijben, Jilske A., Stel, Vianda S., Kerschbaum, Julia, Ots-Rosenberg, Mai, Åsberg, Anders A., Lopot, Frantisek, Golan, Eliezer, Castro De La Nuez, Pablo, Rodríguez Camblor, Marta, Trujillo-Alemán, Sara, Ruiz San Millan, Juan Carlos, Ucio Mingo, Pablo, Díaz, Juan Manuel, Bouzas-Caamaño, M. Encarnación, Artamendi, Marta, Aparicio Madre, Manuel I., Santiuste De Pablos, Carmen, Slon Roblero, María Fernanda, Zurriaga, Oscar, Stendahl, Maria E., Bell, Samira, Idrizi, Alma, Ioannou, Kyriakos, Debska-Slizien, Alicja, Galvão, Ana A., De Meester, Johan M., Resić, Halima, Hommel, Kristine, Radunovic, Danilo, Pálsson, Runolfur, Lassalle, Mathilde, Finne, Patrik, De Los Ángeles-Garcia Bazaga, María, Gjorgjievski, Nikola, Seyahi, Nurhan, Bonthuis, Marjolein, Ortiz, Alberto, Jager, Kitty J., Kramer, Anneke, Boenink, Rianne, Astley, Megan E., Huijben, Jilske A., Stel, Vianda S., Kerschbaum, Julia, Ots-Rosenberg, Mai, Åsberg, Anders A., Lopot, Frantisek, Golan, Eliezer, Castro De La Nuez, Pablo, Rodríguez Camblor, Marta, Trujillo-Alemán, Sara, Ruiz San Millan, Juan Carlos, Ucio Mingo, Pablo, Díaz, Juan Manuel, Bouzas-Caamaño, M. Encarnación, Artamendi, Marta, Aparicio Madre, Manuel I., Santiuste De Pablos, Carmen, Slon Roblero, María Fernanda, Zurriaga, Oscar, Stendahl, Maria E., Bell, Samira, Idrizi, Alma, Ioannou, Kyriakos, Debska-Slizien, Alicja, Galvão, Ana A., De Meester, Johan M., Resić, Halima, Hommel, Kristine, Radunovic, Danilo, Pálsson, Runolfur, Lassalle, Mathilde, Finne, Patrik, De Los Ángeles-Garcia Bazaga, María, Gjorgjievski, Nikola, Seyahi, Nurhan, Bonthuis, Marjolein, Ortiz, Alberto, Jager, Kitty J., and Kramer, Anneke

Abstract

Background: Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Methods: Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. Results: In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.

Published
2022

19. MO865: Epidemiological Characteristics of Cancer in Incident Dialysis Patients. A Multicentre Spanish Study

Author

Alonso Garcia, Fabiola, primary, Garcia, Patricia, additional, Almenara Tejederas, Marina, additional, García Santiago, Ana, additional, Rosa Melero Martin, Maria, additional, Teresa Villaverde Ares, Maria, additional, Gutiérrez, Elena, additional, del Mar Castilla Castellano, María, additional, Díaz Díez, Irene, additional, Castro de la Nuez, Pablo, additional, Salgueira Lazo, Mercedes, additional, and Molas Flores, Rocío, additional

Published
2022
Full Text
View/download PDF

20. The ERA Registry Annual Report 2019: summary and age comparisons

Author

Boenink, Rianne, Astley, Megan E., Huijben, Jilske A., Stel, Vianda S., Kerschbaum, Julia, Ots-Rosenberg, Mai, Åsberg, Anders A., Lopot, Frantisek, Golan, Eliezer, Castro de la Nuez, Pablo, Rodríguez Camblor, Marta, Trujillo-Alemán, Sara, Ruiz San Millan, Juan Carlos, Ucio Mingo, Pablo, Díaz Gómez, Juan Manuel, Bouzas-Caamaño, M. Encarnación, Artamendi, Marta, Aparicio Madre, Manuel I, Santiuste de Pablos, Carmen, Slon Roblero, María Fernanda, Zurriaga, Oscar, Stendahl, Maria E., Bell, Samira, Idrizi, Alma, Ioannou, Kyriakos, Debska-Slizien, Alicja, Galvão, Ana A., De Meester, Johan, Resić, Halima, Hommel, Kristine, Radunovic, Danilo, Pálsson, Runolfur, Lassalle, Mathilde, Finne, Patrik, Garcia Bazaga, María De los Ángeles, Gjorgjievski, Nikola, Seyahi, Nurhan, Bonthuis, Marjolein, Ortiz, Alberto, Jager, Kitty J., Kramer, Anneke, Universitat Autònoma de Barcelona, Department of Medicine, Clinicum, Nefrologian yksikkö, Helsinki University Hospital Area, Graduate School, Medical Informatics, APH - Aging & Later Life, APH - Quality of Care, APH - Methodology, APH - Health Behaviors & Chronic Diseases, APH - Global Health, ACS - Pulmonary hypertension & thrombosis, and UAM. Departamento de Medicina

Subjects
Transplantation, patient survival, Medicina, Nephrology, 3121 General medicine, internal medicine and other clinical medicine, graft survival, dialysis, kidney transplantation, epidemiology, ESRD, 3126 Surgery, anesthesiology, intensive care, radiology
Abstract

Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar, y los autores pertenecientes a la UAM, Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Methods: Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities, The ERA Registry is funded by the ERA. This article was written by R. Boenink et al. on behalf of the ERA Registry, which is an official body of the ERA. In addition, S.B. reports personal fees from AstraZeneca, outside the submitted work; A.D.-S. reports personal fees from Astellas and Fresenius, outside the submitted work; F.L. reports personal fees from MeditesPharma, outside the submitted work; R.P. reports grants from The Iceland Centre for Research, Landspitali University Hospital Research Fund and University of Iceland Research Fund, outside the submitted work; P.F. reports grants from Finska läkaresällskapet and Liv och Hälsa, outside the submitted work; M.F.S.R. reports personal fees from Baxter and Fresenius, outside the submitted work; A.O. reports grants from Sanofi, and personal fees from Astellas, AstraZeneca, Amicus, Bayes, Fresenius Medical Care and Idorsia, outside the submitted work; and K.J.J. reports grants from ERA, during the conduct of the study

Published
2022

21. The ERA Registry Annual Report 2019: summary and age comparisons

Author

Boenink, Rianne, primary, Astley, Megan E, additional, Huijben, Jilske A, additional, Stel, Vianda S, additional, Kerschbaum, Julia, additional, Ots-Rosenberg, Mai, additional, Åsberg, Anders A, additional, Lopot, Frantisek, additional, Golan, Eliezer, additional, Castro de la Nuez, Pablo, additional, Rodríguez Camblor, Marta, additional, Trujillo-Alemán, Sara, additional, Ruiz San Millan, Juan Carlos, additional, Ucio Mingo, Pablo, additional, Díaz, Juan Manuel, additional, Bouzas-Caamaño, M Encarnación, additional, Artamendi, Marta, additional, Aparicio Madre, Manuel I, additional, Santiuste de Pablos, Carmen, additional, Slon Roblero, María Fernanda, additional, Zurriaga, Oscar, additional, Stendahl, Maria E, additional, Bell, Samira, additional, Idrizi, Alma, additional, Ioannou, Kyriakos, additional, Debska-Slizien, Alicja, additional, Galvão, Ana A, additional, De Meester, Johan M, additional, Resić, Halima, additional, Hommel, Kristine, additional, Radunovic, Danilo, additional, Pálsson, Runolfur, additional, Lassalle, Mathilde, additional, Finne, Patrik, additional, De los Ángeles-Garcia Bazaga, María, additional, Gjorgjievski, Nikola, additional, Seyahi, Nurhan, additional, Bonthuis, Marjolein, additional, Ortiz, Alberto, additional, Jager, Kitty J, additional, and Kramer, Anneke, additional

Published
2021
Full Text
View/download PDF

22. Years of Potential Life Lost on Renal Replacement Therapy: Retrospective Study Cohort.

Author

Muñoz-Terol, José Manuel, Rocha, José L., Castro-de la Nuez, Pablo, García-Cabrera, Emilio, and Vilches-Arenas, Ángel

Subjects
RENAL replacement therapy, CHRONIC kidney failure, NON-communicable diseases, KIDNEY diseases, COHORT analysis, HEMODIALYSIS patients, KIDNEY transplantation
Abstract

Background: Chronic kidney disease is the non-communicable disease with the highest growth in morbidity and mortality. Renal transplantation (RT) is the first option of renal replacement in end-stage kidney disease (ESKD) and dialysis is an alternative. However, there is no objective quantification of the impact of both options on a patient's overall survival. The purpose of our study is to assess the potential years of life lost by patients on renal replacement therapy. Methods: Retrospective study cohort conducted from 2008 to 2018 based on autonomic data registry. Results: 11,551 patients included who received renal replacement therapy (RRT) in a range of age from 15 to 94 years. The mean age at the time of onset was 62.7 years, 95% confidence interval (95% CI) (62.4; 63.0). The mortality rate of RRT patients was 42.2%, 95% CI (41.5; 43.3) and the mean age at death was 72.7 years, 95% CI (72.4; 73.1). The number of patients with ESKD treated with RT was 3776, 32.7% of the total, 95% CI (31.8; 33.5). The total amount of years of potential life lost (YPLL) in the entire cohort was 77,831.3 years, 48,010.1 years in men, and 29,821.2 years in women. The mean number of YPLL per patient with RRT was 6.74 years in both sexes, 6.95 years in women, and 6.61 years in men. The mean number of potential years of life lost in dialysis patients was 9.0 years in both sexes, 8.8 years in men, and 9.2 years in women, while among kidney transplant recipients this figure decreased to 2.2 years in both men and women. Conclusions: End-stage chronic kidney disease in renal replacement therapy by dialysis causes an average of 9.0 years of life potentially lost for each patient on dialysis treatment, while having received a kidney transplant reduces this figure by 75.6%. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

23. Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report

Author

Kramer, Anneke, Stel, Vianda S., Abad Diez, José Maria, Alonso de la Torre, Ramón, Bouzas Caamaño, Encarnación, Čala, Svjetlana, Cao Baduell, Higini, Castro de la Nuez, Pablo, Cernevskis, Harijs, Collart, Frederic, Couchoud, Cécile, de Meester, Johan, Djukanovic, Ljubica, Ferrer-Alamar, Manuel, Finne, Patrik, Fogarty, Damian, de los Ángeles García Bazaga, María, Garneata, Liliana, Golan, Eliezer, González Fernández, Raquel, Heaf, James G., Hoitsma, Andries, Ioannidis, George A., Kolesnyk, Mykola, Kramar, Reinhard, Leivestad, Torbjørn, Limido, Aurelio, Lopot, Frantisek, Macario, Fernando, Magaz, Ángela, Martín-Escobar, Eduardo, Metcalfe, Wendy, Noordzij, Marlies, Ots-Rosenberg, Mai, Palsson, Runolfur, Piñera, Celestino, Postorino, Maurizio, Prutz, Karl G., Ratkovic, Marina, Resic, Halima, Rodríguez Hernández, Aurelio, Rutkowski, Boleslaw, Serdengeçti, Kamil, Yebenes, Tomas Sierra, Spustová, Viera, Stojceva-Taneva, Olivera, Tomilina, Natalia A., van de Luijtgaarden, Moniek W.M., van Stralen, Karlijn J., Wanner, Christoph, Jager, Kitty J., Universitat Autònoma de Barcelona, Amsterdam Cardiovascular Sciences, Amsterdam Public Health, and Medical Informatics

Subjects
medicine.medical_specialty, Ronyons -- Malalties -- Pacients -- Europa -- Estadístiques, medicine.medical_treatment, Population, 030232 urology & nephrology, 030204 cardiovascular system & hematology, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Renal replacement therapy, education, Dialysis, Transplantation, education.field_of_study, business.industry, Incidence (epidemiology), Medical record, Special Feature, Confidence interval, 3. Good health, Educational Papers, Nephrology, Hemodialysis, business
Abstract

BACKGROUND: This study provides a summary of the 2010 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at www.era-edta-reg.org). METHODS: This report includes data on renal replacement therapy (RRT) using data from the national and regional renal registries in 29 countries in Europe and bordering the Mediterranean Sea. Individual patient data were received from 27 registries, whereas 18 registries contributed data in aggregated form. We present incidence and prevalence of RRT, transplant rates, survival probabilities and expected remaining lifetimes. The latter two are solely based on individual patient records. RESULTS: In 2010, the overall incidence rate of RRT for end-stage renal disease (ESRD) among all registries reporting to the ERA-EDTA Registry was 123 per million population (pmp) (n = 91 798). The highest incidence rate was reported by Turkey (252pmp) and the lowest reported by Montenegro (21 pmp). The overall prevalence of RRT for ESRD at 31 December 2010 among all registries reporting to the ERA-EDTA Registry was 741 pmp (n = 551 005). The prevalence varied from 124 pmp in Ukraine to 1580 pmp in Portugal. The overall number of renal transplantations performed in 2010 among all registries was 29.2 pmp (n = 21 740). The highest overall transplant rate was reported from Spain, Cantabria (73 pmp), whereas the highest transplant rate for living donor kidneys was reported from the Netherlands (28 pmp). For patients who started RRT between 2001 and 2005, the unadjusted 5-year patient survival on RRT was 46.2% [95% confidence interval (CI) 46.0-46.3], and on dialysis 38.6% (95% CI 38.5-38.8). The unadjusted 5-year patient survival after the first renal transplantation performed between 2001 and 2005 was 86.6% (95% CI 86.1-87.1) for deceased donor kidneys and 94.1% (95% CI 93.4-94.8) for living donor kidneys.

Published
2021

24. The ERA Registry Annual Report 2019 : summary and age comparisons

Author

Boenink, Rianne, Astley, Megan E, Huijben, Jilske A, Stel, Vianda S, Kerschbaum, Julia, Ots-Rosenberg, Mai, Åsberg, Anders A, Lopot, Frantisek, Golan, Eliezer, Castro de la Nuez, Pablo, Rodríguez Camblor, Marta, Trujillo-Alemán, Sara, Ruiz San Millan, Juan Carlos, Ucio Mingo, Pablo, Díaz Gómez, Juan Manuel, Bouzas-Caamaño, M Encarnación, Artamendi, Marta, Aparicio Madre, Manuel I, Santiuste de Pablos, Carmen, Slon Roblero, María Fernanda, Zurriaga, Oscar, Stendahl, Maria E, Bell, Samira, Idrizi, Alma, Ioannou, Kyriakos, Debska-Slizien, Alicja, Galvão, Ana A, De Meester, Johan M, Resić, Halima, Hommel, Kristine, Radunovic, Danilo, Pálsson, Runolfur, Lassalle, Mathilde, Finne, Patrik, De los Ángeles-Garcia Bazaga, María, Gjorgjievski, Nikola, Seyahi, Nurhan, Bonthuis, Marjolein, Ortiz, Alberto, Jager, Kitty J, Kramer, Anneke, Universitat Autònoma de Barcelona, Boenink, Rianne, Astley, Megan E, Huijben, Jilske A, Stel, Vianda S, Kerschbaum, Julia, Ots-Rosenberg, Mai, Åsberg, Anders A, Lopot, Frantisek, Golan, Eliezer, Castro de la Nuez, Pablo, Rodríguez Camblor, Marta, Trujillo-Alemán, Sara, Ruiz San Millan, Juan Carlos, Ucio Mingo, Pablo, Díaz Gómez, Juan Manuel, Bouzas-Caamaño, M Encarnación, Artamendi, Marta, Aparicio Madre, Manuel I, Santiuste de Pablos, Carmen, Slon Roblero, María Fernanda, Zurriaga, Oscar, Stendahl, Maria E, Bell, Samira, Idrizi, Alma, Ioannou, Kyriakos, Debska-Slizien, Alicja, Galvão, Ana A, De Meester, Johan M, Resić, Halima, Hommel, Kristine, Radunovic, Danilo, Pálsson, Runolfur, Lassalle, Mathilde, Finne, Patrik, De los Ángeles-Garcia Bazaga, María, Gjorgjievski, Nikola, Seyahi, Nurhan, Bonthuis, Marjolein, Ortiz, Alberto, Jager, Kitty J, Kramer, Anneke, and Universitat Autònoma de Barcelona

Abstract

Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.

Published
2021

25. The ERA-EDTA Registry Annual Report 2017

Author

Kramer, Anneke, Boenink, Rianne, Noordzij, Marlies, Bosdriesz, Jizzo R., Stel, Vianda S., Beltrán, Palma, Ruiz, Juan C., Seyahi, Nurhan, Comas Farnés, Jordi, Stendahl, Maria, Garneata, Liliana, Winzeler, Rebecca, Golan, Eliezer, Lopot, František, Korejwo, Grzegorz, Bonthuis, Marjolein, Lassalle, Mathilde, Slon Roblero, María F., Kuzema, Viktorija, Hommel, Kristine, Stojceva-Taneva, Olivera, Åsberg, Anders, Kramar, Reinhard, Hemmelder, Marc H., de Meester, Johan, Vazelov, Evgueniy, Andrusev, Anton M., Castro de la Nuez, Pablo, Helve, Jaakko, Komissarov, Kirill, Casula, Anna, Magaz, Ángela, Santiuste de Pablos, Carmen, Bubic, Ivan, Traynor, Jamie P., Ioannou, Kyriakos, Idrizi, Alma, Palsson, Runolfur, des Grottes, Jean-Marin, Spustova, Viera, Tolaj-Avdiu, Miloreta, Nordio, Maurizio, Ziginskiene, Edita, Massy, Ziad A., Jager, Kitty J., APH - Quality of Care, APH - Aging & Later Life, ACS - Pulmonary hypertension & thrombosis, Medical Informatics, Graduate School, Infectious diseases, APH - Methodology, APH - Health Behaviors & Chronic Diseases, Amsterdam Gastroenterology Endocrinology Metabolism, and APH - Global Health

Published
2020

26. The ERA-EDTA Registry Annual Report 2017: a summary

Author

Kramer, Anneke, primary, Boenink, Rianne, additional, Noordzij, Marlies, additional, Bosdriesz, Jizzo R, additional, Stel, Vianda S, additional, Beltrán, Palma, additional, Ruiz, Juan C, additional, Seyahi, Nurhan, additional, Comas Farnés, Jordi, additional, Stendahl, Maria, additional, Garneata, Liliana, additional, Winzeler, Rebecca, additional, Golan, Eliezer, additional, Lopot, František, additional, Korejwo, Grzegorz, additional, Bonthuis, Marjolein, additional, Lassalle, Mathilde, additional, Slon Roblero, Maria F, additional, Kuzema, Viktorija, additional, Hommel, Kristine, additional, Stojceva-Taneva, Olivera, additional, Asberg, Anders, additional, Kramar, Reinhard, additional, Hemmelder, Marc H, additional, De Meester, Johan, additional, Vazelov, Evgueniy, additional, Andrusev, Anton, additional, Castro de la Nuez, Pablo, additional, Helve, Jaakko, additional, Komissarov, Kirill, additional, Casula, Anna, additional, Magaz, Ángela, additional, Santiuste de Pablos, Carmen, additional, Bubić, Ivan, additional, Traynor, Jamie P, additional, Ioannou, Kyriakos, additional, Idrizi, Alma, additional, Palsson, Runolfur, additional, des Grottes, Jean-Marin, additional, Spustova, Viera, additional, Tolaj-Avdiu, Miloreta, additional, Jarraya, Faical, additional, Nordio, Maurizio, additional, Ziginskiene, Edita, additional, Massy, Ziad A, additional, and Jager, Kitty J, additional

Published
2020
Full Text
View/download PDF

27. Optimal start in dialysis shows increased survival in patients with chronic kidney disease

Author

Medicina, Caro Martínez, Araceli, Olry de Labry Lima, Antonio, Muñoz Terol, José Manuel, Mendoza García, Óscar Javier, Remón Rodríguez, César, García Mochón, Leticia, Castro de la Nuez, Pablo, Aresté Fosalba, Nuria, Medicina, Caro Martínez, Araceli, Olry de Labry Lima, Antonio, Muñoz Terol, José Manuel, Mendoza García, Óscar Javier, Remón Rodríguez, César, García Mochón, Leticia, Castro de la Nuez, Pablo, and Aresté Fosalba, Nuria

Abstract

Objective To compare the survival among patients with chronic kidney disease who had optimal starts of renal replacement therapy, dialysis or hemodialysis, with patients who had suboptimal starts. Methods A retrospective cohort consisting of >18 year-old patients who started renal replacement therapy, using peritoneal dialysis or hemodialysis, in any public hospital or associated center of the Andalusian Public Health System, between the 1st of January of 2006 and the 15th of March of 2017. The optimal start was defined when all the following criteria were met: a planned dialysis start, a minimum of six-month follow-up by a nephrologist, and a first dialysis method coinciding with the one registered at 90 days. The information was obtained from the registry of the Information System of the Transplant Autonomic Coordination of Andalusia. Results A total of 10,692 patients were studied. 4,377 (40.9%) of these patients died. A total of 4,937 patients (46.17%) achieved optimal starts of renal replacement therapy and showed higher survival rates (HR 0.669; 95% CI 0.628–0.712) in the multivariate analysis of Cox regression model.

Published
2019

28. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016:a summary

Author

Kramer, Anneke, Pippias, Maria, Noordzij, Marlies, Stel, Vianda S, Andrusev, Anton M, Aparicio-madre, Manuel I, Arribas Monzón, Federico E, Åsberg, Anders, Barbullushi, Myftar, Beltrán, Palma, Bonthuis, Marjolein, Caskey, Fergus J, Castro De La Nuez, Pablo, Cernevskis, Harijs, De Meester, Johan, Finne, Patrik, Golan, Eliezer, Heaf, James G., Hemmelder, Marc H, Ioannou, Kyriakos, Kantaria, Nino, Komissarov, Kirill, Korejwo, Grzegorz, Kramar, Reinhard, Lassalle, Mathilde, Lopot, František, Macário, Fernando, Mackinnon, Bruce, Pálsson, Runólfur, Pechter, Ülle, Piñera, Vicente C, Santiuste De Pablos, Carmen, Segarra-medrano, Alfons, Seyahi, Nurhan, Slon Roblero, Maria F, Stojceva-taneva, Olivera, Vazelov, Evgueniy, Winzeler, Rebecca, Ziginskiene, Edita, Massy, Ziad, Jager, Kitty J, Kramer, Anneke, Pippias, Maria, Noordzij, Marlies, Stel, Vianda S, Andrusev, Anton M, Aparicio-madre, Manuel I, Arribas Monzón, Federico E, Åsberg, Anders, Barbullushi, Myftar, Beltrán, Palma, Bonthuis, Marjolein, Caskey, Fergus J, Castro De La Nuez, Pablo, Cernevskis, Harijs, De Meester, Johan, Finne, Patrik, Golan, Eliezer, Heaf, James G., Hemmelder, Marc H, Ioannou, Kyriakos, Kantaria, Nino, Komissarov, Kirill, Korejwo, Grzegorz, Kramar, Reinhard, Lassalle, Mathilde, Lopot, František, Macário, Fernando, Mackinnon, Bruce, Pálsson, Runólfur, Pechter, Ülle, Piñera, Vicente C, Santiuste De Pablos, Carmen, Segarra-medrano, Alfons, Seyahi, Nurhan, Slon Roblero, Maria F, Stojceva-taneva, Olivera, Vazelov, Evgueniy, Winzeler, Rebecca, Ziginskiene, Edita, Massy, Ziad, and Jager, Kitty J

Published
2019

33. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary

Author

Kramer, Anneke, primary, Pippias, Maria, additional, Noordzij, Marlies, additional, Stel, Vianda S, additional, Andrusev, Anton M, additional, Aparicio-Madre, Manuel I, additional, Arribas Monzón, Federico E, additional, Åsberg, Anders, additional, Barbullushi, Myftar, additional, Beltrán, Palma, additional, Bonthuis, Marjolein, additional, Caskey, Fergus J, additional, Castro de la Nuez, Pablo, additional, Cernevskis, Harijs, additional, De Meester, Johan, additional, Finne, Patrik, additional, Golan, Eliezer, additional, Heaf, James G, additional, Hemmelder, Marc H, additional, Ioannou, Kyriakos, additional, Kantaria, Nino, additional, Komissarov, Kirill, additional, Korejwo, Grzegorz, additional, Kramar, Reinhard, additional, Lassalle, Mathilde, additional, Lopot, František, additional, Macário, Fernando, additional, Mackinnon, Bruce, additional, Pálsson, Runólfur, additional, Pechter, Ülle, additional, Piñera, Vicente C, additional, Santiuste de Pablos, Carmen, additional, Segarra-Medrano, Alfons, additional, Seyahi, Nurhan, additional, Slon Roblero, Maria F, additional, Stojceva-Taneva, Olivera, additional, Vazelov, Evgueniy, additional, Winzeler, Rebecca, additional, Ziginskiene, Edita, additional, Massy, Ziad, additional, and Jager, Kitty J, additional

Published
2019
Full Text
View/download PDF

34. Does the Kidney Donor Profile Index (KDPI) predict graft and patient survival in a Spanish population?

Author

Universidad de Sevilla. Departamento de Ingeniería de Sistemas y Automática, Universidad de Sevilla. Departamento de Ingeniería Telemática, Universidad de Sevilla. TIC203: Ingenieria Biomedica, Fondo de Investigación Sanitaria, Calvillo Arbizu, Jorge, Pérez Valdivia, Miguel Angel, Gentil Govantes, Miguel Ángel, Castro de la Nuez, Pablo, Mazuecos Blanca, Auxiliadora, Rodríguez Benot, Alberto, Gracia Guindo, María, Borrego Utiel, Francisco, Cabello Díaz, Mercedes, Bedoya Pérez, Rafael, Alonso Gil, Manuel, Salgueira Lazo, Mercedes, Roa Romero, Laura Maria, Universidad de Sevilla. Departamento de Ingeniería de Sistemas y Automática, Universidad de Sevilla. Departamento de Ingeniería Telemática, Universidad de Sevilla. TIC203: Ingenieria Biomedica, Fondo de Investigación Sanitaria, Calvillo Arbizu, Jorge, Pérez Valdivia, Miguel Angel, Gentil Govantes, Miguel Ángel, Castro de la Nuez, Pablo, Mazuecos Blanca, Auxiliadora, Rodríguez Benot, Alberto, Gracia Guindo, María, Borrego Utiel, Francisco, Cabello Díaz, Mercedes, Bedoya Pérez, Rafael, Alonso Gil, Manuel, Salgueira Lazo, Mercedes, and Roa Romero, Laura Maria

Abstract

Background and objective: The Kidney Donor Profile Index (KDPI), together with other donor and recipient variables, can optimise the organ allocation process. This study aims to check the feasibility of the KDPI for a Spanish population and its predictive ability of graft and patient survival. Materials and methods: Data from 2734 kidney transplants carried out in Andalusia between January 2006 and December 2015 were studied. Cases were grouped by recipient age, categorised by KDPI quartile and both graft and patient survival were compared among groups. Results: The KDPI accurately discriminated optimal organs from suboptimal or marginal ones. For adult recipients (aged: 18–59 years) it presents a hazard ratio of 1.013 (P < 0.001) for death-censored graft survival and of 1.013 (P = 0.007) for patient survival. For elderly recipients (aged: 60+ years), KDPI presented a hazard ratio of 1.016 (P = 0.001) for death-censored graft survival and of 1.011 (P = 0.0007) for patient survival. A multivariate analysis identified the KDPI, donor age, donation after circulatory death, recipient age and gender as predictive factors of graft survival. Conclusions: The results obtained show that the KDPI makes it possible to relate the donor’s characteristics with the greater or lesser survival of the graft and the patient in the Spanish population. However, due to certain limitations, a new index for Spain based on Spanish or European data should be created. In this study, some predictive factors of graft survival are identified that may serve as a first step in this path., Antecedentes y objetivo: El Kidney Donor Profile Index (KDPI), junto a otras variables del donante y receptor, puede optimizar el proceso de asignación de órganos. Este estudio tiene como objetivo comprobar la aplicabilidad del KDPI en una población espanola, ˜ así como su capacidad de predicción de la supervivencia del injerto y del paciente. Materiales y métodos: Se estudiaron 2.734 trasplantes renales llevados a cabo en Andalucía entre enero de 2006 y diciembre de 2015. Los casos se agruparon por edad del receptor y cuartil del KDPI y se compararon entre grupos tanto la supervivencia del injerto como la del paciente. Resultados: El KDPI discrimina con precisión los órganos óptimos de los subóptimos o marginales. Para receptores entre 18 y 59 anos ˜ presenta un hazard ratio de 1,013 (p < 0,001) para supervivencia de injerto censurada para muerte y de 1,013 (p = 0,007) para supervivencia del paciente. Para receptores mayores de 60 anos ˜ el hazard ratio es de 1,016 (p = 0,001) para supervivencia del injerto censurada para muerte y de 1,011 (p = 0,007) para supervivencia del paciente. Un análisis multivariante identificó como factores predictivos de la supervivencia del injerto el KDPI, la edad del donante, la donación tras muerte circulatoria, la edad y el sexo del receptor. Conclusiones: El KDPI permite relacionar, a grandes rasgos, las características del donante con la mayor o menor supervivencia del injerto y del paciente en la población espanola. ˜ No obstante, debido a ciertas limitaciones, convendría elaborar un índice propio a partir de los datos espanoles ˜ o europeos. En este trabajo se identifican algunos factores predictivos de la supervivencia del injerto que pueden servir como primer paso en esa línea.

Published
2018

36. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary

Author

Kramer, Anneke, primary, Pippias, Maria, additional, Noordzij, Marlies, additional, Stel, Vianda S, additional, Afentakis, Nikolaos, additional, Ambühl, Patrice M, additional, Andrusev, Anton M, additional, Fuster, Emma Arcos, additional, Arribas Monzón, Federico E, additional, Åsberg, Anders, additional, Barbullushi, Myftar, additional, Bonthuis, Marjolein, additional, Caskey, Fergus J, additional, Castro de la Nuez, Pablo, additional, Cernevskis, Harijs, additional, des Grottes, Jean-Marin, additional, Garneata, Liliana, additional, Golan, Eliezer, additional, Hemmelder, Marc H, additional, Ioannou, Kyriakos, additional, Jarraya, Faical, additional, Kolesnyk, Mykola, additional, Komissarov, Kirill, additional, Lassalle, Mathilde, additional, Macario, Fernando, additional, Mahillo-Duran, Beatriz, additional, Martín de Francisco, Angel L, additional, Palsson, Runolfur, additional, Pechter, Ülle, additional, Resic, Halima, additional, Rutkowski, Boleslaw, additional, Santiuste de Pablos, Carmen, additional, Seyahi, Nurhan, additional, Simic Ogrizovic, Sanja, additional, Slon Roblero, María F, additional, Spustova, Viera, additional, Stojceva-Taneva, Olivera, additional, Traynor, Jamie, additional, Massy, Ziad A, additional, and Jager, Kitty J, additional

Published
2018
Full Text
View/download PDF

37. Sistema de Información de la Coordinación Autonómica de Trasplantes de Andalucía (SICATA) : Subsistema de Insuficiencia Renal Crónica : Informe 2014

Author

Castro de la Nuez, Pablo, Muñoz Terol, José Manuel, and Alonso Gil, Manuel

Subjects
Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings], Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic [Medical Subject Headings], Trasplante de riñon, Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic::Kidney Failure, Chronic [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Transplantation::Organ Transplantation::Kidney Transplantation [Medical Subject Headings], Dialisis renal, Andalucía, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy::Renal Dialysis [Medical Subject Headings], Insuficiencia renal crónica, Dialisis peritoneal, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy::Renal Dialysis::Peritoneal Dialysis::Peritoneal Dialysis, Continuous Ambulatory [Medical Subject Headings]
Abstract

Publicación que contiene datos de prevalencia, incidencia y mortalidad de los pacientes con insuficiencia renal crónica terminal en tratamiento sustitutivo residentes en nuestra Comunidad.

Published
2016

39. The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary

Author

Pippias, Maria, primary, Kramer, Anneke, additional, Noordzij, Marlies, additional, Afentakis, Nikolaos, additional, Alonso de la Torre, Ramón, additional, Ambühl, Patrice M., additional, Aparicio Madre, Manuel I., additional, Arribas Monzón, Felipe, additional, Åsberg, Anders, additional, Bonthuis, Marjolein, additional, Bouzas Caamaño, Encarnación, additional, Bubic, Ivan, additional, Caskey, Fergus J., additional, Castro de la Nuez, Pablo, additional, Cernevskis, Harijs, additional, de los Ángeles Garcia Bazaga, Maria, additional, des Grottes, Jean-Marin, additional, Fernández González, Raquel, additional, Ferrer-Alamar, Manuel, additional, Finne, Patrik, additional, Garneata, Liliana, additional, Golan, Eliezer, additional, Heaf, James G., additional, Hemmelder, Marc H., additional, Idrizi, Alma, additional, Ioannou, Kyriakos, additional, Jarraya, Faical, additional, Kantaria, Nino, additional, Kolesnyk, Mykola, additional, Kramar, Reinhard, additional, Lassalle, Mathilde, additional, Lezaic, Visnja V., additional, Lopot, Frantisek, additional, Macario, Fernando, additional, Magaz, Ángela, additional, Martín de Francisco, Angel L., additional, Martín Escobar, Eduardo, additional, Martínez Castelao, Alberto, additional, Metcalfe, Wendy, additional, Moreno Alia, Inmaculada, additional, Nordio, Maurizio, additional, Ots-Rosenberg, Mai, additional, Palsson, Runolfur, additional, Ratkovic, Marina, additional, Resic, Halima, additional, Rutkowski, Boleslaw, additional, Santiuste de Pablos, Carmen, additional, Seyahi, Nurhan, additional, Fernanda Slon Roblero, María, additional, Spustova, Viera, additional, Stas, Koenraad J.F., additional, Stendahl, María E., additional, Stojceva-Taneva, Olivera, additional, Vazelov, Evgueniy, additional, Ziginskiene, Edita, additional, Massy, Ziad, additional, Jager, Kitty J., additional, and Stel, Vianda S., additional

Published
2017
Full Text
View/download PDF

40. Mortalidad en lista de espera para trasplante renal

Author

Hernández, Domingo, Castro-de la Nuez, Pablo, Muriel, Alfonso, Ruiz-Esteban, Pedro, and Alonso, Manuel

Subjects
Kidney transplantation, Trasplante renal, Lista de espera, Mortalidad, Waiting list, Diálisis, Comorbidity, Riesgo competitivo, Mortality, Competing risk, Comorbilidad, Dialysis
Abstract

El trasplante renal (Tx) representa el tratamiento de elección para los pacientes con enfermedad renal crónica avanzada (ERC), pero la escasez de órganos disponibles para aquellos con gran comorbilidad puede incrementar significativamente la mortalidad en enfermos candidatos a Tx. Esto constituye un problema sanitario preocupante, dado el incremento de los pacientes incidentes y prevalentes con ERC, especialmente de aquellos con ERC secundaria a entidades de gran comorbilidad como la diabetes y la hipertensión arterial. Asimismo, este hecho puede incrementar el número de pacientes en lista de espera (LE) y disparar sus cifras de mortalidad. Por tanto, actualmente resulta pertinente identificar las causas de muerte y los factores de riesgo de mortalidad en esta población, conocer las barreras que limitan el acceso al Tx y aplicar modelos predictivos de mortalidad en aras de mejorar los resultados de estos enfermos en términos de supervivencia. En esta revisión sobre la mortalidad de los pacientes en LE se abordarán los siguientes aspectos: 1) la magnitud de este problema y la importancia de algunos datos epidemiológicos; 2) los factores de riesgo de mortalidad en estos enfermos y las barreras que existen para el acceso al Tx que pudieran incrementar la mortalidad en esta población; 3) evaluación del riesgo de muerte de los pacientes en diálisis a partir de la comorbilidad; y 4) valoración de la mortalidad en LE mediante análisis de regresión de riesgos competitivos y la generación de un modelo de riesgo compuesto, incluyendo la comorbilidad y otros factores urémicos. Renal transplantation (Tx) represents the treatment of choice for patients with advanced chronic kidney disease (ACKD), but the shortage of available organs for those with a high level of comorbidity can significantly increase mortality in patients who are candidates for Tx. This constitutes a worrying health care problem, given the increase in incident and prevalent patients with ACKD, and is especially concerning amongst those with ACKD that is secondary to conditions with a high level of comorbidity, such as diabetes or arterial hypertension. In addition, this can increase the number of patients on the waiting list (WL) and cause the rapid raising of mortality figures. Therefore, nowadays it is relevant to identify the causes of death and the mortality risk factors in this population, to know the barriers that limit access to Tx and to apply predictive mortality models, with the aim of improving survival rates from these illnesses. In this review on the mortality of the patients on the WL, the following aspects will be addressed: 1) the magnitude of this problem and the importance of certain epidemiological data; 2) the mortality risk factors in these patients and the barriers that exist against access to Tx, which could increase mortality rates amongst this population; 3) evaluation of the risk of death in patients on dialysis from comorbidity; 4) assessment of mortality on the WL, via regression analysis of competitive risks, and the generation of a compound risk model, which includes comorbidity and other uraemic factors.

Published
2015

41. Mortalidad en lista de espera para trasplante renal

Author

Hernández,Domingo, Castro-de la Nuez,Pablo, Muriel,Alfonso, Ruiz-Esteban,Pedro, and Alonso,Manuel

Subjects
Trasplante renal, Lista de espera, Mortalidad, Diálisis, Riesgo competitivo, Comorbilidad
Abstract

El trasplante renal (Tx) representa el tratamiento de elección para los pacientes con enfermedad renal crónica avanzada (ERC), pero la escasez de órganos disponibles para aquellos con gran comorbilidad puede incrementar significativamente la mortalidad en enfermos candidatos a Tx. Esto constituye un problema sanitario preocupante, dado el incremento de los pacientes incidentes y prevalentes con ERC, especialmente de aquellos con ERC secundaria a entidades de gran comorbilidad como la diabetes y la hipertensión arterial. Asimismo, este hecho puede incrementar el número de pacientes en lista de espera (LE) y disparar sus cifras de mortalidad. Por tanto, actualmente resulta pertinente identificar las causas de muerte y los factores de riesgo de mortalidad en esta población, conocer las barreras que limitan el acceso al Tx y aplicar modelos predictivos de mortalidad en aras de mejorar los resultados de estos enfermos en términos de supervivencia. En esta revisión sobre la mortalidad de los pacientes en LE se abordarán los siguientes aspectos: 1) la magnitud de este problema y la importancia de algunos datos epidemiológicos; 2) los factores de riesgo de mortalidad en estos enfermos y las barreras que existen para el acceso al Tx que pudieran incrementar la mortalidad en esta población; 3) evaluación del riesgo de muerte de los pacientes en diálisis a partir de la comorbilidad; y 4) valoración de la mortalidad en LE mediante análisis de regresión de riesgos competitivos y la generación de un modelo de riesgo compuesto, incluyendo la comorbilidad y otros factores urémicos.

Published
2015

42. Sistema de Información de la Coordinación Autonómica de Trasplantes de Andalucía (SICATA) : Subsistema de Insuficiencia Renal Crónica : Informe 2013

Author

Castro de la Nuez, Pablo, Muñoz Terol, José Manuel, and Alonso Gil, Manuel

Subjects
Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings], Fallo renal crónico, Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic [Medical Subject Headings], Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic::Kidney Failure, Chronic [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Transplantation::Organ Transplantation::Kidney Transplantation [Medical Subject Headings], Trasplante de riñón, Andalucía, Diálisis peritoneal, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy::Renal Dialysis [Medical Subject Headings], Insuficiencia renal crónica, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy::Renal Dialysis::Peritoneal Dialysis::Peritoneal Dialysis, Continuous Ambulatory [Medical Subject Headings], Diálisis renal
Abstract

Coordinación Autonómica de Trasplantes Esta publicación contiene datos de prevalencia, incidencia y mortalidad de los pacientes con insuficiencia renal crónica terminal en tratamiento sustitutivo, residentes en nuestra comunidad. Yes

Published
2014

43. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus

Author

Kramer, Anneke, primary, Pippias, Maria, additional, Stel, Vianda S., additional, Bonthuis, Marjolein, additional, Abad Diez, José Maria, additional, Afentakis, Nikolaos, additional, Alonso de la Torre, Ramón, additional, Ambuhl, Patrice, additional, Bikbov, Boris, additional, Bouzas Caamaño, Encarnación, additional, Bubic, Ivan, additional, Buturovic-Ponikvar, Jadranka, additional, Caskey, Fergus J., additional, Castro de la Nuez, Pablo, additional, Cernevskis, Harijs, additional, Collart, Frederic, additional, Comas Farnés, Jordi, additional, Garcia Bazaga, Maria de los Ángeles, additional, De Meester, Johan, additional, Ferrer Alamar, Manuel, additional, Finne, Patrik, additional, Garneata, Liliana, additional, Golan, Eliezer, additional, G. Heaf, James, additional, Hemmelder, Marc, additional, Ioannou, Kyriakos, additional, Kantaria, Nino, additional, Kolesnyk, Mykola, additional, Kramar, Reinhard, additional, Lassalle, Mathilde, additional, Lezaic, Visnja, additional, Lopot, Frantisek, additional, Macário, Fernando, additional, Magaz, Angela, additional, Martín-Escobar, Eduardo, additional, Metcalfe, Wendy, additional, Ots-Rosenberg, Mai, additional, Palsson, Runolfur, additional, Piñera Celestino, Celestino, additional, Resić, Halima, additional, Rutkowski, Boleslaw, additional, Santiuste de Pablos, Carmen, additional, Spustová, Viera, additional, Stendahl, Maria, additional, Strakosha, Ariana, additional, Süleymanlar, Gültekin, additional, Torres Guinea, Marta, additional, Varberg Reisæter, Anna, additional, Vazelov, Evgueniy, additional, Ziginskiene, Edita, additional, Massy, Ziad A., additional, Wanner, Christoph, additional, Jager, Kitty J., additional, and Noordzij, Marlies, additional

Published
2016
Full Text
View/download PDF

44. Sistema de Información de la Coordinación Autonómica de Trasplantes de Andalucía (SICATA) : Subsistema de Insuficiencia Renal Crónica : Informe 2011

Author

Castro de la Nuez, Pablo, Gil Sacaluga, Luis, Gentil Govantes, Miguel Angel, and Alonso Gil, Manuel

Subjects
Diseases::Female Urogenital Diseases and Pregnancy Complications::Female Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic::Kidney Failure, Chronic [Medical Subject Headings], Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings], Diseases::Endocrine System Diseases::Adrenal Gland Diseases::Adrenal Insufficiency [Medical Subject Headings], Insuficiencia Renal Crónica, Health Care::Health Care Facilities, Manpower, and Services::Health Services::Patient Care::Ambulatory Care::Peritoneal Dialysis, Continuous Ambulatory [Medical Subject Headings], Diállisis Renal, Diálisis Peritoneal, Trasplante de Riñon, Andalucía, Fallo Renal Crónico, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Sorption Detoxification::Renal Dialysis [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Urogenital Surgical Procedures::Urologic Surgical Procedures::Kidney Transplantation [Medical Subject Headings]
Abstract

Esta publicación contiene datos de prevalencia, incidencia y mortalidad de los pacientes con insuficiencia renal crónica terminal en tratamiento sustitutivo, residentes en nuestra comunidad. Yes

Published
2012

45. Guía de Biovigilancia de Órganos, Células y Tejidos de Andalucía

Author

Alonso Gil, Manuel, Alvarez Marquez, Antonia, Benitez Ruiz, Lourdes, Castro de la Nuez, Pablo, Daga Ruiz, Domingo, Diaz Aunión, Concepción, Garrote Lara, Daniel, Huet Ruiz-Matas, Jesús, Navarro Holgado, Pablo, Pereira Gutiérrez, Gertrudis, Villalba Montoro, Rafael, and Grupo de Trabajo de Biovigilancia de Andalucía

Subjects
Trasplantes de órganos, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Equipment and Supplies::Transplants [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Transplantation::Cell Transplantation [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Transplantation::Organ Transplantation [Medical Subject Headings], Andalucía, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Transplantation::Tissue Transplantation [Medical Subject Headings], Trasplantes, Trasplantes de células, Trasplantes de tejidos
Abstract

Coordinación Autonómica de Trasplantes. Dirección General de Asistencia Sanitaria. Servicio Andaluz de Salud La presente Guía ha sido elaborada por el Grupo de Trabajo de Biovigilancia de Andalucía con el objetivo de unificar y mejorar la actuación de todos los profesionales que intervienen en el proceso de donación y trasplantes de órganos, células y tejidos, y recoge el circuito a seguir en caso de detectar un incidente o una reacción adversa relacionada con el uso terapéutico de células y tejidos humanos y el trasplante de órganos. Incluye un listado de posibles incidentes y reacciones adversas elaborado por el grupo de trabajo de Biovigilancia, con la colaboración y aportaciones de profesionales expertos y consensuado con diferentes Equipos Andaluces de trasplantes de órganos y la Comisión de trasplantes de progenitores hematopoyéticos de Andalucía. Yes

Published
2011

46. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report

Author

Pippias, Maria, primary, Stel, Vianda S., additional, Abad Diez, José Maria, additional, Afentakis, Nikolaos, additional, Herrero-Calvo, Jose Antonio, additional, Arias, Manuel, additional, Tomilina, Natalia, additional, Bouzas Caamaño, Encarnación, additional, Buturovic-Ponikvar, Jadranka, additional, Čala, Svjetlana, additional, Caskey, Fergus J., additional, Castro de la Nuez, Pablo, additional, Cernevskis, Harijs, additional, Collart, Frederic, additional, Alonso de la Torre, Ramón, additional, García Bazaga, Maria de los Ángeles, additional, De Meester, Johan, additional, Díaz, Joan Manuel, additional, Djukanovic, Ljubica, additional, Ferrer Alamar, Manuel, additional, Finne, Patrik, additional, Garneata, Liliana, additional, Golan, Eliezer, additional, González Fernández, Raquel, additional, Gutiérrez Avila, Gonzalo, additional, Heaf, James, additional, Hoitsma, Andries, additional, Kantaria, Nino, additional, Kolesnyk, Mykola, additional, Kramar, Reinhard, additional, Kramer, Anneke, additional, Lassalle, Mathilde, additional, Leivestad, Torbjørn, additional, Lopot, Frantisek, additional, Macário, Fernando, additional, Magaz, Angela, additional, Martín-Escobar, Eduardo, additional, Metcalfe, Wendy, additional, Noordzij, Marlies, additional, Palsson, Runolfur, additional, Pechter, Ülle, additional, Prütz, Karl G., additional, Ratkovic, Marina, additional, Resić, Halima, additional, Rutkowski, Boleslaw, additional, Santiuste de Pablos, Carmen, additional, Spustová, Viera, additional, Süleymanlar, Gültekin, additional, Van Stralen, Karlijn, additional, Thereska, Nestor, additional, Wanner, Christoph, additional, and Jager, Kitty J., additional

Published
2015
Full Text
View/download PDF

47. Células y tejidos humanos: proceso asistencial integrado

Author

Alonso Gil, Manuel, Álvarez Márquez, Antonia, Arias Trejo, Pilar, Benítez Ruiz, Lourdes, Castro de la Nuez, Pablo, Frutos Sanz, Miguel Ángel, Hernández Lamas, Mª Carmen, Hoyos Sanabria, Belén, Lara Rosales, Ramón, Navarro Holgado, Pablo, Ortega Vinuesa, Francisco, Suárez Ramos, Amalia, and Villalba Montoro, Rafael

Subjects
Guía de práctica clínica, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Health Care::Health Services Administration::Quality of Health Care [Medical Subject Headings], Obtención de tejidos y órganos, Anatomy::Tissues [Medical Subject Headings], Anatomy::Cells [Medical Subject Headings], Andalucía, Trasplantes, Anatomy::Body Regions::Transplants [Medical Subject Headings], Calidad de la atención de salud, Health Care::Health Care Facilities, Manpower, and Services::Health Services::Tissue and Organ Procurement [Medical Subject Headings], Publication Type::Publication Formats::Guideline::Practice Guideline [Medical Subject Headings]
Abstract

Yes La Gestión por Procesos es una herramienta con la que se analizan los diversos componentes que intervienen en la prestación sanitaria para ordenar los diferentes flujos de trabajo de la misma, integrar el conocimiento actualizado y procurar cierto énfasis en los resultados obtenidos, teniendo en cuenta las expectativas que tienen ciudadanas, ciudadanos y profesionales, e intentando disminuir la variabilidad de las actuaciones en salud hasta lograr un grado de homogeneidad óptimo. Este proceso abarca desde la fase inicial de obtención de células y tejidos hasta la fase final de su implante, contemplando también el procesamiento, almacenamiento y distribución de los mismos, garantizando su trazabilidad y la biovigilancia.

Published
2009

48. Trasplante de páncreas : proceso asistencial integrado

Author

Burgos Rodríguez, Dolores, Muñoz Terol, José Manuel, Navarro Cabello, Mª Dolores, Milán Martín, José Antonio, Berlango Jiménez, José, Aguilar Diosdado, Manuel, Corpas Jiménez, Mª Sierra, Ruiz de Adana, Marisol, Jiménez de la Cruz, Manuel, Navarro Piñero, Alfonso, Padillo Ruiz, Javier, Regueiro López, Juan Carlos, Baena González, Víctor, Castro de la Nuez, Pablo, Mayoral Sánchez, Eduardo, and Suárez Ramos, Amalia

Subjects
Protocolos clínicos-Normas, Health Care::Health Services Administration::Quality of Health Care [Medical Subject Headings], Trasplante de páncreas, Publication Characteristics::Publication Formats::Guideline::Practice Guideline [Medical Subject Headings], Atención dirigida al paciente, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Digestive System Surgical Procedures::Pancreas Transplantation [Medical Subject Headings]
Abstract

Publicado en la página web de la Consejería de Igualdad, Salud y Políticas Sociales: www.juntadeandalucia.es/salud (Consejería de Igualdad, Salud y Políticas Sociales/ Profesionales / Nuestro Compromiso por la Calidad / Procesos Asistenciales Integrados). Yes Proceso de atención a la persona diabética, con o sin insuficiencia renal crónica (IRC), cuya opción terapéutica es el trasplante de páncreas con o sin trasplante renal asociado.

Published
2008

49. ¿Predice el Kidney Donor Profile Index(KDPI) la supervivencia del injerto y del paciente en una población española?

Author

Calvillo-Arbizu, Jorge, Pérez-Valdivia, Miguel A., Gentil-Govantes, Miguel A., Castro-de-la-Nuez, Pablo, Mazuecos-Blanca, Auxiliadora, Rodríguez-Benot, Alberto, Gracia-Guindo, María C., Borrego-Utiel, Francisco, Cabello-Díaz, Mercedes, Bedoya-Pérez, Rafael, Alonso-Gil, Manuel, Salgueira-Lazo, Mercedes, and Roa-Romero, Laura M.

Abstract

El Kidney Donor Profile Index(KDPI), junto a otras variables del donante y receptor, puede optimizar el proceso de asignación de órganos. Este estudio tiene como objetivo comprobar la aplicabilidad del KDPI en una población española, así como su capacidad de predicción de la supervivencia del injerto y del paciente.

Published
2018
Full Text
View/download PDF

50. Renal replacement therapy in Europe—a summary of the 2010 ERA–EDTA Registry Annual Report

Author

Kramer, Anneke, primary, Stel, Vianda S., additional, Abad Diez, José Maria, additional, Alonso de la Torre, Ramón, additional, Bouzas Caamaño, Encarnación, additional, Čala, Svjetlana, additional, Cao Baduell, Higini, additional, Castro de la Nuez, Pablo, additional, Cernevskis, Harijs, additional, Collart, Frederic, additional, Couchoud, Cécile, additional, de Meester, Johan, additional, Djukanovic, Ljubica, additional, Ferrer-Alamar, Manuel, additional, Finne, Patrik, additional, Fogarty, Damian, additional, de los Ángeles García Bazaga, María, additional, Garneata, Liliana, additional, Golan, Eliezer, additional, Gonzalez Fernández, Raquel, additional, Heaf, James G., additional, Hoitsma, Andries, additional, Ioannidis, George A., additional, Kolesnyk, Mykola, additional, Kramar, Reinhard, additional, Leivestad, Torbjørn, additional, Limido, Aurelio, additional, Lopot, Frantisek, additional, Macario, Fernando, additional, Magaz, Ángela, additional, Martín-Escobar, Eduardo, additional, Metcalfe, Wendy, additional, Noordzij, Marlies, additional, Ots-Rosenberg, Mai, additional, Palsson, Runolfur, additional, Piñera, Celestino, additional, Postorino, Maurizio, additional, Prutz, Karl G., additional, Ratkovic, Marina, additional, Resic, Halima, additional, Rodríguez Hernández, Aurelio, additional, Rutkowski, Boleslaw, additional, Serdengeçti, Kamil, additional, Yebenes, Tomas Sierra, additional, Spustová, Viera, additional, Stojceva-Taneva, Olivera, additional, Tomilina, Natalia A., additional, van de Luijtgaarden, Moniek W.M., additional, van Stralen, Karlijn J., additional, Wanner, Christoph, additional, and Jager, Kitty J., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results